Sodyum Valproat ile İndüklenen Tip 2 Sitrulinemi

Hayasaka K, Numakura C. Adult-onset type II citrullinemia: current insights and therapy. Appl Clin Genet 2018;11:163-170.
Tang L, Chen L, Wang H, Dai L, Pan S. Case report: an adult-onset type II citrin deficiency patient in the emergency department. Exp Ther Med 2016;12:410-414.
Takahashi Y, Koyama S, Tanaka H, et al. An elderly Japanese patient with adult-onset type II citrullinemia with a novel D493G mutation in the SLC25A13 gene. Intern Med 2012;51:2131- 2134.
Haberle J, Rubio V. In: Saudubray JM, Baumgartner MR, Walter J (eds). Disorders of the Urea Cycle and Related Enzymes. Inborn Metabolic Disease. 6th edition. Berlin Heidelberg, PA: Springer; 2016;295-308.
Saheki T, Inoue K, Tushima A, Mutoh K, Kobayashi K. Citrin deficiency and current treatment concepts. Mol Genet Metab 2010;100(Suppl 1):S59-S64.
Ikeda S, Yazaki M, Takei Y, et al. Type II (adult onset) citrullinaemia: clinical pictures and the therapeutic effect of liver transplantation. J Neurol Neurosurg Psychiatry 2001;71:663-670.
Majoie CB, Mourmans JM, Akkerman EM, Duran M, Poll-The BT. Neonatal citrullinemia: comparison of conventional MR, diffusion-weighted, and diffusion tensor findings. AJNR Am J Neuroradiol 2004;25:32-35.